Latest Advances
Cure SMA shares a variety of different research-focused updates with our spinal muscular atrophy (SMA) community. Check out the various types of announcements below and visit Latest News for updates.
![basic-research-award-grant-icon basic-research-award-grant-icon](https://www.curesma.org/wp-content/uploads/2023/01/basic-research-award-grant-icon.png)
Basic research grant awards
Every spring, we announce the recipients of our basic research grants. They are researchers pursuing the most promising ideas that can lead to new SMA treatments.
![drug-discovery-grant-icon drug-discovery-grant-icon](https://www.curesma.org/wp-content/uploads/2023/01/drug-discovery-grant-icon.png)
Drug discovery grant awards
Periodically, we announce new drug discovery funding. These grants help turn basic research ideas into specific drug candidates that can be tested in clinical trials.
![clinical-trial-recruitment-icon clinical-trial-recruitment-icon](https://www.curesma.org/wp-content/uploads/2023/01/clinical-trial-recruitment-icon.png)
Clinical trial recruitment announcements
We regularly post information about clinical trials that are currently recruiting participants. Depending on several factors, you may choose to enroll yourself or your child in a clinical trial.
![data-releases-icon data-releases-icon](https://www.curesma.org/wp-content/uploads/2023/01/data-releases-icon.png)
Data releases
Clinical trial sponsors periodically release data from ongoing trials.
![regulatory-updates-icon regulatory-updates-icon](https://www.curesma.org/wp-content/uploads/2023/01/regulatory-updates-icon.png)
Regulatory updates
Once a clinical trial is completed, the sponsor will evaluate all the data. If the data shows the drug is safe and effective, the sponsor will file for approval with government regulators.
![approval-icon approval-icon](https://www.curesma.org/wp-content/uploads/2023/01/approval-icon.png)
Approval
After the FDA and international regulators review a drug for safety and effectiveness, they will issue a ruling. If the drug is approved, doctors can then begin to prescribe it to eligible patients.